Biao Mu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Biao Mu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Da Pan
NHC Key Laboratory of Hormones and Development (Tianjin Medical University), Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin, 300134, China
2 shared publicationsLihui Yan
NHC Key Laboratory of Hormones and Development (Tianjin Medical University), Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin, 300134, China
2 shared publicationsYanan Shi
NHC Key Laboratory of Hormones and Development (Tianjin Medical University), Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin, 300134, China
2 shared publicationsHengyu Chen
NHC Key Laboratory of Hormones and Development (Tianjin Medical University), Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin, 300134, China
1 shared publicationJihong Yuan
Tianjin Medical University
1 shared publication- Jihong Yuan
NHC Key Laboratory of Hormones and Development (Tianjin Medical University), Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin, 300134, China
1 shared publication
Latest Publications
- 1 June 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 526 (3) , 733-737
Salvianolic acid B improved insulin resistance through suppression of hepatic ER stress in ob/ob mice
- 1 June 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 526 (3) , 733-737
Salvianolic acid B improved insulin resistance through suppression of hepatic ER stress in ob/ob mice
- Open Access
- 12 April 2020
- Published by Springer Nature in Research Square
Salvianolic acid B ameliorates hepatocyte lipid droplet accumulation via stimulation of autophagy
Salvianolic acid B (Sal B) the most abundant bioactive member in Salvia miltiorrhiza and has been reported lots of benefits on the treatment of cardio-cerebral vascular diseases and metabolic diseases. Lipid droplets are dynamic organelles, excessive lipid droplets accumulation in liver caused fatty liver disease. In this study, we are interested in the effect of Sal B on hepatic lipid accumulation and its possible mechanism. We found Sal B treatment significantly decreased lipid accumulation and TG level in primary hepatocytes, this is the first demonstration for the effect of Sal B on lipid droplets. Meanwhile, a stimulation of Sal B on autophagy of hepatocytes was discovered, further we used autophagy inhibitor 3-MA and reveled that after administration of 3-MA Sal B showed little effect on improving hepatic lipid accumulation, this means the effects of Sal B on lipid drop depend on autophagy. This study demonstrates Sal B ameliorate hepatic lipid accumulation through activation of autophagy. These findings contribute to its benefit on liver disease related to hepatic lipid accumulation and hepatic autophagy.
- 12 April 2020
- Published by Springer Nature in Research Square
Open AccessSalvianolic acid B ameliorates hepatocyte lipid droplet accumulation via stimulation of autophagy
Salvianolic acid B (Sal B) the most abundant bioactive member in Salvia miltiorrhiza and has been reported lots of benefits on the treatment of cardio-cerebral vascular diseases and metabolic diseases. Lipid droplets are dynamic organelles, excessive lipid droplets accumulation in liver caused fatty liver disease. In this study, we are interested in the effect of Sal B on hepatic lipid accumulation and its possible mechanism. We found Sal B treatment significantly decreased lipid accumulation and TG level in primary hepatocytes, this is the first demonstration for the effect of Sal B on lipid droplets. Meanwhile, a stimulation of Sal B on autophagy of hepatocytes was discovered, further we used autophagy inhibitor 3-MA and reveled that after administration of 3-MA Sal B showed little effect on improving hepatic lipid accumulation, this means the effects of Sal B on lipid drop depend on autophagy. This study demonstrates Sal B ameliorate hepatic lipid accumulation through activation of autophagy. These findings contribute to its benefit on liver disease related to hepatic lipid accumulation and hepatic autophagy.